<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: The use of plasma <z:chebi fb="11" ids="18295">histamine</z:chebi> determinations as a screening tool to distinguish patients with recurrent unexplained <z:mp ids='MP_0002531'>anaphylaxis</z:mp>, flushing, or both from those with <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> has never been evaluated </plain></SENT>
<SENT sid="1" pm="."><plain>This retrospective study was designed to determine if plasma <z:chebi fb="11" ids="18295">histamine</z:chebi> levels can be used as a screening test </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHODS: Values of plasma <z:chebi fb="11" ids="18295">histamine</z:chebi> levels, measured using a sensitive radioenzymatic assay, from 41 patients with <z:hpo ids='HP_0100495'>mastocytosis</z:hpo>, 26 patients with recurrent unexplained <z:mp ids='MP_0002531'>anaphylaxis</z:mp>, and 76 <z:mpath ids='MPATH_458'>normal</z:mpath> subjects were statistically analyzed to determine diagnostic usefulness and accuracy </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> were subdivided into four smaller groups on the basis of clinical and histopathologic findings: (1) isolated <z:hpo ids='HP_0001025'>urticaria</z:hpo> pigmentosa, (2) indolent systemic <z:hpo ids='HP_0100495'>mastocytosis</z:hpo>, (3) <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> with <z:e sem="disease" ids="C0026986" disease_type="Neoplastic Process" abbrv="MDS">dysmyelopoiesis</z:e>, and (4) lymphadenopathic <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> with <z:hpo ids='HP_0001880'>eosinophilia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The distribution of plasma <z:chebi fb="11" ids="18295">histamine</z:chebi> values among patients with unexplained <z:mp ids='MP_0002531'>anaphylaxis</z:mp> strongly resembled that among the <z:mpath ids='MPATH_458'>normal</z:mpath> subjects (p greater than 0.50, Smirnov test), whereas patients with <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> tended to show moderate to marked elevations above the upper limit of <z:mpath ids='MPATH_458'>normal</z:mpath> (617 pg/mL) </plain></SENT>
<SENT sid="5" pm="."><plain>The geometric mean plasma <z:chebi fb="11" ids="18295">histamine</z:chebi> levels in <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> subgroups 2, 3, and 4 were found to be quite similar (1,085, 1,976, and 1,433 pg/mL; p greater than 0.50, F-test); moreover, each mean level was significantly greater than those of the <z:mpath ids='MPATH_458'>normal</z:mpath> subjects and of patients with unexplained <z:mp ids='MP_0002531'>anaphylaxis</z:mp> (p less than 0.01, Scheff√© multiple comparison test) </plain></SENT>
<SENT sid="6" pm="."><plain>Analysis of the 27 sets of plasma <z:chebi fb="11" ids="18295">histamine</z:chebi> values collected on patients with indolent systemic <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> revealed that the earliest value observed fell below 617 pg/mL in eight patients (30%) </plain></SENT>
<SENT sid="7" pm="."><plain>A similar analysis applied to the two earlier values indicated that both values would fall below 617 pg/mL in 9% of the patients </plain></SENT>
<SENT sid="8" pm="."><plain>Data in four patients with <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> demonstrated a diurnal variation in plasma <z:chebi fb="11" ids="18295">histamine</z:chebi>, with the highest values observed in the early morning (approximately 2:00 A.M.) and the lowest values in the afternoon (approximately 2:00 P.M.) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: We conclude that, on average, patients with <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> have elevated plasma <z:chebi fb="11" ids="18295">histamine</z:chebi> levels, whereas patients with unexplained <z:mp ids='MP_0002531'>anaphylaxis</z:mp> have plasma <z:chebi fb="11" ids="18295">histamine</z:chebi> levels within the <z:mpath ids='MPATH_458'>normal</z:mpath> range during asymptomatic periods; that plasma <z:chebi fb="11" ids="18295">histamine</z:chebi> levels in patients with <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> exhibit a diurnal variation; and that plasma <z:chebi fb="11" ids="18295">histamine</z:chebi> determinations alone are not useful to screen patients for <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> </plain></SENT>
</text></document>